0001707032-17-000001.txt : 20170519 0001707032-17-000001.hdr.sgml : 20170519 20170519103255 ACCESSION NUMBER: 0001707032-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170519 DATE AS OF CHANGE: 20170519 EFFECTIVENESS DATE: 20170519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FundRx, Inc. CENTRAL INDEX KEY: 0001707032 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-287114 FILM NUMBER: 17856715 BUSINESS ADDRESS: STREET 1: 71 BROADWAY STREET 2: LEVEL 2B #102 CITY: NEW YORK STATE: NY ZIP: 10006 BUSINESS PHONE: (646) 751-7942 MAIL ADDRESS: STREET 1: 71 BROADWAY STREET 2: LEVEL 2B #102 CITY: NEW YORK STATE: NY ZIP: 10006 D 1 primary_doc.xml X0707 D LIVE 0001707032 FundRx, Inc. 71 Broadway Level 2B #102 New York NY NEW YORK 10006 (646) 751-7942 DELAWARE None None Corporation true 2015 Zeshan Muhammedi c/o FundRx, Inc. 71 Broadway, Level 2B #102 New York NY NEW YORK 10006 Executive Officer Director Gurdane Bhutani c/o FundRx, Inc. 71 Broadway, Level 2B #102 New York NY NEW YORK 10006 Executive Officer Director Mohammad Jainal Bhuiyan c/o FundRx, Inc. 71 Broadway, Level 2B #102 New York NY NEW YORK 10006 Director Aziz Hashim c/o FundRx, Inc. 71 Broadway, Level 2B #102 New York NY NEW YORK 10006 Director Other Health Care Decline to Disclose 06b false 2017-05-05 false true true Offer and sale of Series Seed and Series Seed-1 Preferred Stock, and the underlying shares of Common Stock issuable upon conversion thereof. false 0 5000000 1391975 3608025 Total amount sold includes the value of cancelled indebtedness formerly held by certain purchasers in the aggregate principal and interest amount of $736,978.44. false 25 0 0 350000 true false FundRx, Inc. /s/ Zeshan Muhammedi Zeshan Muhammedi Chief Executive Officer 2017-05-19